As part of our dissemination activities, the , held on 20-21 June 2024 in Montpellier, France. The workshop, titled “ENOTTA – European Network on Optimising Treatment with Therapeutic Antibodies in chronic inflammatory diseases: Assembling a Multidisciplinary Puzzle,” showcased significant advancements in optimizing therapeutic antibody treatments for chronic inflammatory diseases, while outlining the objectives, ongoing activities and achievements of ENOTTA.
Under the leadership of @Denis Mulleman, Chair of ENOTTA, and featuring distinguished speakers like @George Kararigas (WG5 Leader), @Azra Guzonjić (WG5 Co-Leader), and @Ana Homšek (WG2 Steering Committee representative), the workshop highlighted collaborative efforts aimed at enhancing treatment efficacy and improving patient outcomes.
During the event, Azra Guzonjić and Ana Homšek, supported by ITC grants from ENOTTA, also presented their primary research posters.
This symposium not only emphasized the importance of multidisciplinary collaboration but also underscored ENOTTA’s dedication to advancing therapeutic antibody research and application in clinical settings.
Special recognition goes to @Ana Antunes for her instrumental role as the main organizer of this enlightening event.
Stay connected with ENOTTA on LinkedIn for more updates and join us in our mission to optimize treatment strategies with therapeutic antibodies.
Learn more about ENOTTA at enotta.eu
#ENOTTA #COSTAction #TherapeuticAntibodies #IMIDs #AISCongress #Science #Research
